Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 11 , ISSUE 4 ( October-December, 2022 ) > List of Articles

Original Article

Prevalence and Predictors of Osteoporosis in Patients of Interstitial Lung Disease: An Observational Study from North India

Deepak Aggarwal, Anshu Palta, Rohit Jindal, Anuj Kumar, Mandeep Kaur Sodhi, Varinder Saini

Keywords : Bone mineral density, cross-sectional study, idiopathic pulmonary fibrosis, osteoporosis, predictors, prevalence, risk factors

Citation Information : Aggarwal D, Palta A, Jindal R, Kumar A, Sodhi MK, Saini V. Prevalence and Predictors of Osteoporosis in Patients of Interstitial Lung Disease: An Observational Study from North India. Indian J Respir Care 2022; 11 (4):353-357.

DOI: 10.4103/ijrc.ijrc_86_22

License: CC BY-NC-SA 4.0

Published Online: 01-12-2022

Copyright Statement:  Copyright © 2022; Indian Journal of Respiratory Care.


Background: Osteoporosis has been widely reported in chronic respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis. However, there is a scarcity of data on its prevalence and risk factors in interstitial lung disease (ILD), particularly in Indian patients. Aims: The present study was conducted to determine the prevalence and predictors of osteoporosis in ILD patients. Materials and Methods: We conducted a cross-sectional study, in which ILD patients presenting to the hospital were enrolled. After collecting demographic and clinical data, the patients underwent a dual-energy x-ray absorptiometry scan of the femoral neck to measure bone mineral density. Osteoporosis was diagnosed based on their T-scores, following the World Health Organization guidelines. Univariate and multivariate logistic regression analyses were performed to determine the risk factors of osteoporosis in ILD. Results: The mean age of the 97 ILD patients was 55.7 + 12.6 years (range 28-84 years) with the predominance of females (n = 61). Osteoporosis was detected in 39 (40.2%) patients. Female gender, duration of symptoms, and low hemoglobin level had a positive association with osteoporosis on univariate analysis (P < 0.05). However, duration of symptoms (adjusted odds ratio [OR]-1.29; 95% confidence interval CI-1.02-1.63; P = 0.04) and hemoglobin level (adjusted OR-0.59; 95% CI-0.39-0.89; P = 0.01) were the independent risk factors of osteoporosis on multivariate analysis. Conclusion: Osteoporosis is common comorbidity seen in ILD patients. A longer duration of ILD symptoms and low hemoglobin level can predict the presence of osteoporosis in these patients.

  1. Clarson LE, Bajpai R, Whittle R, Belcher J, Abdul Sultan A, Kwok CS, et al. Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction. Heart 2020;106:916-22.
  2. Troy LK, Corte TJ. Sleep disordered breathing in interstitial lung disease: A review. World J Clin Cases 2014;2:828-34.
  3. King CS, Nathan SD. Pulmonary hypertension due to interstitial lung disease. Curr Opin Pulm Med 2019;25:459-67.
  4. Hershcovici T, Jha LK, Johnson T, Gerson L, Stave C, Malo J, et al. Systematic review: The relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011;34:1295-305.
  5. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 2012;17:525-32.
  6. Chen YW, Ramsook AH, Coxson HO, Bon J, Reid WD. Prevalence and risk factors for osteoporosis in individuals with COPD: A systematic review and meta-analysis. Chest 2019;156:1092-110.
  7. Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998;19:555-67.
  8. Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW, et al. Osteoporosis before lung transplantation: Association with low body mass index, but not with underlying disease. Am J Transplant 2002;2:167-72.
  9. Okazaki R, Watanabe R, Inoue D. Osteoporosis associated with chronic obstructive pulmonary disease. J Bone Metab 2016;23:111-20.
  10. Lu PC, Yang YH, Guo SE, Yang TM. Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease – A nationwide retrospective study. Osteoporos Int 2017;28:359-67.
  11. Caplan-Shaw CE, Arcasoy SM, Shane E, Lederer DJ, Wilt JS, O'Shea MK, et al. Osteoporosis in diffuse parenchymal lung disease. Chest 2006;129:140-6.
  12. Alhamad EH, Nadama R. Bone mineral density in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2015;32:151-9.
  13. Kumar R, Gupta N, Goel N. Spectrum of interstitial lung disease at a tertiary care centre in India. Pneumonol Alergol Pol 2014;82:218-26.
  14. Sen T, Udwadia ZF. Retrospective study of interstitial lung disease in a tertiary care centre in India. Indian J Chest Dis Allied Sci 2010;52:207-11.
  15. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198:e44-68.
  16. Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48.
  17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
  18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
  19. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4:368-81.
  20. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
  21. Malhotra N, Mithal A. Osteoporosis in Indians. Indian J Med Res 2008;127:263-8.
  22. Babhulkar S, Seth S. Prevalence of osteoporosis in India: An observation of 31238 adults. Int J Res Orthop 2021;7:362-8.
  23. Desai O, Winkler J, Minasyan M, Herzog EL. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front Med (Lausanne) 2018;5:43.
  24. Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G. Hypersensitivity pneumonitis: Current concepts of pathogenesis and potential targets for treatment. Am J Respir Crit Care Med 2019;200:301-8.
  25. Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration 2007;74:159-69.
  26. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 1996;132:195-210.
  27. Akkawi I, Zmerly H. Osteoporosis: Current concepts. Joints 2018;6:122-7.
  28. Khadilkar AV, Mandlik RM. Epidemiology and treatment of osteoporosis in women: An Indian perspective. Int J Womens Health 2015;7:841-50.
  29. Mitrache C, Passweg JR, Libura J, Petrikkos L, Seiler WO, Gratwohl A, et al. Anemia: An indicator for malnutrition in the elderly. Ann Hematol 2001;80:295-8.
  30. Pan ML, Chen LR, Tsao HM, Chen KH. Iron deficiency anemia as a risk factor for osteoporosis in Taiwan: A nationwide population-based study. Nutrients 2017;9:616.
  31. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194:S3-11.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.